First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
暂无分享，去创建一个
James X. Sun | F. Meric-Bernstam | D. Fabrizio | S. Kopetz | Siraj M. Ali | F. Janku | A. Naing | D. Hong | S. Piha-Paul | A. Tsimberidou | M. Overman | B. Amini | G. Falchook | V. Subbiah | C. Eng | S. Fu | A. Schrock | D. Karp | Adrienne Johnson | Hui Liu | M. Khawaja | Jiang Yungfang